1. Home
  2. CTLP vs VALN Comparison

CTLP vs VALN Comparison

Compare CTLP & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cantaloupe Inc.

CTLP

Cantaloupe Inc.

HOLD

Current Price

$9.98

Market Cap

798.9M

Sector

Technology

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$10.85

Market Cap

875.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTLP
VALN
Founded
1992
2012
Country
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
798.9M
875.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CTLP
VALN
Price
$9.98
$10.85
Analyst Decision
Hold
Strong Buy
Analyst Count
3
4
Target Price
N/A
$15.75
AVG Volume (30 Days)
1.6M
12.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.11
$3.64
Revenue Next Year
$14.37
$12.23
P/E Ratio
$13.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.01
$5.43
52 Week High
$11.36
$12.25

Technical Indicators

Market Signals
Indicator
CTLP
VALN
Relative Strength Index (RSI) 19.74 67.90
Support Level $10.37 $9.95
Resistance Level $10.74 $10.40
Average True Range (ATR) 0.17 0.29
MACD -0.07 0.10
Stochastic Oscillator 1.11 98.04

Price Performance

Historical Comparison
CTLP
VALN

About CTLP Cantaloupe Inc.

Cantaloupe Inc is a technology leader powering self-service commerce by offering one integrated solution for payments processing, logistics, and back-office management. The group offers a comprehensive suite of solutions, including micro-payment processing, self-checkout kiosks, mobile ordering, connected point-of-sale (POS) systems, and enterprise cloud software. Its product and services portfolio consists of Card Readers, Self-Service Kiosks, Smart Coolers, Seed Pick Easy, Cantaloupe Go, Cheq, Smart Lock Connect, and Vine Digital Studio. The company derives revenue streams from subscriptions, transaction processing, and equipment sales.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: